Melanoma-Derived Extracellular Vesicles Induce CD36-Mediated Pre-Metastatic Niche.

Area of Science:

• Oncology
• Immunology
• Cell Biology

Background:

• CD36 is implicated in cancer metastasis.
• Melanoma extracellular vesicles (EVs) influence tumor microenvironments.
• The role of CD36 in melanoma EVs is not well understood.

Purpose of the Study:

• To investigate the role of CD36 in melanoma progression.
• To determine if melanoma EVs mediate CD36 expression and M2-macrophage polarization.
• To analyze CD36 expression in patient lymph nodes.

Main Methods:

• Analysis of the SKCM dataset for clinical prognosis.
• Quantification of CD36 in lymphatic fluid-derived EVs (LEVs).
• In vitro testing of melanoma EVs on monocytic and endothelial cells.
• Multiplex immunofluorescence (MxIF) imaging of lymph nodes.

Main Results:

• High CD36 levels are associated with poorer clinical prognosis in cutaneous melanoma.
• Melanoma patients show higher baseline CD36 percentage in LEVs.
• Melanoma EVs increase CD36 expression in monocytes and endothelial cells, inducing immunosuppressive M2-macrophage characteristics.
• Elevated CD36 expression was observed in tumor-involved lymph nodes, though not statistically significant.

Conclusions:

• CD36 plays a critical role in establishing an immunosuppressive lymph node microenvironment.
• Melanoma-derived EVs contribute to a protumorigenic niche by upregulating CD36.
• Targeting CD36 may offer therapeutic strategies for melanoma.